Factors associated with adherence in a cohort of HIV positive subjects on a first time PI [protease inhibitor] containing HAART regimen: observational study of the impact of adherence on viral load for a HAART regimen containing Kaletra [lopinavir/ritonavir] vs other selected PI containing HAART
Phase of Trial: Phase IV
Latest Information Update: 19 Nov 2008
At a glance
- Drugs Antiretrovirals; HIV protease inhibitors; Lopinavir/ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 19 Nov 2008 Status changed from completed to discontinued, according to clinicaltrials.gov.
- 17 Dec 2007 Status changed from in progress to completed.
- 26 Jun 2007 New trial record.